Key result
Methylprednisolone pulse therapy linked to transient renal failure in ~20% of patients with prior renal impairment.
Why the study?
The effect of methylprednisolone pulse therapy on renal function in patients with renal or collagen disease was examined due to concerns about transient renal failure.
Does methylprednisolone pulse therapy affect renal function in patients with renal or collagen disease?
Observational (n=15)
Does methylprednisolone pulse therapy affect renal function in patients with renal or collagen disease?
Methylprednisolone pulse therapy may induce transient renal failure in patients with nephrotic syndrome and pre-existing renal impairment, possibly due to sodium and water retention.
Answers are grounded in this paper and cite their sources.
MP pulse therapy warrants caution in nephrotic patients with reduced function; Level 5 data leaves open causality and need for prospective trials.
The effect of the methylprednisolone (MP) pulse therapy on renal function was examined in 15 patients with renal or collagen disease. Three nephrotic patients who had reduced renal function and active renal disease with progressive deterioration of renal function prior to the use of MP developed transient renal failure following an MP pulse therapy. The renal failure in each case was reversed by discontinuation of MP and/or by forced diuresis using albumin and furosemide. We examined the correlations between the individual changes in serum creatinine (Scr), body weight (BW) and urine volume (UV) before and after the pulse therapy and other laboratory data such as Scr, total serum protein and albumin. There were significant correlations between a change in Scr on the one hand and changes in BW and UV, Scr and serum albumin on the other. These findings mean that the effect of the MP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an MP therapy and the associated renal interstitial edema, proposed as one of the mechanisms of acute renal failure occurring in patients with minimal-change nephrotic syndrome, may be responsible for the MP-induced transient renal failure.
No takes yet. Share an insight, caveat, or question.
Sakemi et al. (1991) conducted an observational in Renal or collagen disease (n=15). Methylprednisolone pulse therapy was evaluated on Renal function (changes in serum creatinine, body weight, and urine volume). Methylprednisolone pulse therapy induced transient renal failure in 3 of 15 patients, specifically those with prior reduced renal function and active renal disease.
Synapse has enriched 10 related papers. Consider them for comparative context: